Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma

Molecular Medicine Reports
Zhilong HuangZhenli Gao

Abstract

MicroRNAs (miRNAs) are non-coding RNAs that function as regulators of tumor suppressors and oncogenes. A G>C polymorphism (rs2910164) in the miR‑146a precursor sequence leads to a functional change associated with a risk for various types of malignancy. The role of this single nucleotide polymorphism in the pathogenesis of renal cell carcinoma (RCC) has not yet been examined. The present study evaluated the association between rs2910164 genotypes and the risk and prognosis of RCC in a population comprised of 421 RCC cases and 432 controls. Unconditional logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for rs2910164 genotypes according to case status. Cox proportional hazards regression modeling was used to estimate hazards ratios and 95% CIs according to the genotypes among the RCC patients. It was found that the rs2910164 GG and GC genotypes were associated with an increased risk of RCC only in senior subjects (>57‑years old; adjusted OR=1.59, 95% CI=1.04‑2.43). Furthermore, the GC and GG genotypes were associated with a poorer survival rate among patients with RCC compared with the CC genotype (P=0.002). In conclusion, the observed association between the GG and GC genotype and poore...Continue Reading

References

Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·L A MacMillan-CrowJ A Thompson
Jul 29, 1998·The Journal of Urology·O T JanssonN P Wiklund
Aug 29, 2002·The EMBO Journal·Yoontae LeeV Narry Kim
Sep 26, 2003·Nature·Yoontae LeeV Narry Kim
Aug 3, 2004·Nature Reviews. Cancer·Eugenia E Calle, Rudolf Kaaks
Jun 28, 2005·Current Opinion in Genetics & Development·Brian D Harfe
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Jul 28, 2007·American Journal of Epidemiology·Veronica Wendy SetiawanBrian E Henderson
May 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Krystian JazdzewskiAlbert de la Chapelle
Feb 28, 2009·Clinical Chemistry·Claudine L Bartels, Gregory J Tsongalis
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Oct 17, 2009·Digestive Diseases and Sciences·Sheng PengQinghong Cheng
Jan 2, 2010·Neurosurgical Focus·Jay D TurnerM Yashar S Kalani
May 8, 2010·Nature Reviews. Urology·Wong-Ho ChowSusan S Devesa
May 25, 2010·Nature Reviews. Cancer·Bríd M RyanCurtis C Harris
Jul 20, 2010·Breast Cancer Research and Treatment·Lin-Bo GaoLin Zhang
Sep 18, 2010·Journal of Clinical Immunology·Masaaki OkuboTomiyasu Arisawa
Jul 7, 2011·Molecular and Cellular Biology·Jie MeiChun-Li Zhang
Jul 12, 2011·Journal of Neuro-oncology·Jennifer Permuth-WeyKathleen M Egan
Sep 20, 2012·International Journal of Biological Sciences·David J TateArnold H Zea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.